These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12126452)

  • 1. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?
    Suresh GK; Soll RF
    Paediatr Drugs; 2002; 4(8):485-92. PubMed ID: 12126452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
    Walti H; Monset-Couchard M
    Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL
    J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies: synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant.
    Whitelaw A
    J Perinat Med; 1996; 24(5):427-35. PubMed ID: 8950722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis and treatment of respiratory distress syndrome with different surfactants].
    Navas Serrano VM; Cuevas García MA; Vila Alvarez JA; Martínez Fernández V; Morcillo Sopena F; Valls I Soler A
    An Esp Pediatr; 2002 Jan; 56(1):40-4. PubMed ID: 11792243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.
    Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N
    Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal-derived surfactants versus past and current synthetic surfactants: current status.
    Moya F; Maturana A
    Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exogenous surfactant therapy: new synthetic surfactants].
    Lacaze-Masmonteil T
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.